Amara E Ezeamama1, Ezekiel Mupere2, James Oloya3, Leonardo Martinez3, Robert Kakaire3, Xiaoping Yin3, Juliet N Sekandi4, Christopher C Whalen3. 1. Department of Epidemiology and Biostatistics, University of Georgia, B.S. Miller Hall Room 125, 101 Buck Rd, Athens, GA 30602, USA. Electronic address: aezeamam@uga.edu. 2. Department of Pediatrics and Child Health, College of Health Sciences, Makerere University, Kampala, Uganda; Uganda-Case Western Reserve Research Collaboration, Kampala, Uganda. 3. Department of Epidemiology and Biostatistics, University of Georgia, B.S. Miller Hall Room 125, 101 Buck Rd, Athens, GA 30602, USA. 4. Department of Epidemiology and Biostatistics, University of Georgia, B.S. Miller Hall Room 125, 101 Buck Rd, Athens, GA 30602, USA; School of Public Health, College of Health Sciences, Makerere University, Kampala, Uganda.
Abstract
BACKGROUND: Baseline age and combination antiretroviral therapy (cART) were examined as determinants of CD4+ T-cell recovery during 6 months of tuberculosis (TB) therapy with/without cART. It was determined whether this association was modified by patient sex and nutritional status. METHODS: This longitudinal analysis included 208 immune-competent, non-pregnant, ART-naive HIV-positive patients from Uganda with a first episode of pulmonary TB. CD4+ T-cell counts were measured using flow cytometry. Age was defined as ≤24, 25-29, 30-34, and 35-39 vs. ≥40 years. Nutritional status was defined as normal (>18.5kg/m(2)) vs. underweight (≤18.5kg/m(2)) using the body mass index (BMI). Multivariate random effects linear mixed models were fitted to estimate differences in CD4+ T-cell recovery in relation to specified determinants. RESULTS: cART was associated with a monthly rise of 15.7 cells/μl (p<0.001). Overall, age was not associated with CD4+ T-cell recovery during TB therapy (p = 0.655). However, among patients on cART, the age-associated CD4+ T-cell recovery rate varied by sex and nutritional status, such that age <40 vs. ≥40 years predicted superior absolute CD4+ T-cell recovery among females (p=0.006) and among patients with a BMI ≥18.5kg/m(2) (p<0.001). CONCLUSIONS: TB-infected HIV-positive patients aged ≥40 years have a slower rate of immune restoration given cART, particularly if BMI is >18.5kg/m(2) or they are female. These patients may benefit from increased monitoring and nutritional support during cART.
BACKGROUND: Baseline age and combination antiretroviral therapy (cART) were examined as determinants of CD4+ T-cell recovery during 6 months of tuberculosis (TB) therapy with/without cART. It was determined whether this association was modified by patient sex and nutritional status. METHODS: This longitudinal analysis included 208 immune-competent, non-pregnant, ART-naive HIV-positivepatients from Uganda with a first episode of pulmonary TB. CD4+ T-cell counts were measured using flow cytometry. Age was defined as ≤24, 25-29, 30-34, and 35-39 vs. ≥40 years. Nutritional status was defined as normal (>18.5kg/m(2)) vs. underweight (≤18.5kg/m(2)) using the body mass index (BMI). Multivariate random effects linear mixed models were fitted to estimate differences in CD4+ T-cell recovery in relation to specified determinants. RESULTS: cART was associated with a monthly rise of 15.7 cells/μl (p<0.001). Overall, age was not associated with CD4+ T-cell recovery during TB therapy (p = 0.655). However, among patients on cART, the age-associated CD4+ T-cell recovery rate varied by sex and nutritional status, such that age <40 vs. ≥40 years predicted superior absolute CD4+ T-cell recovery among females (p=0.006) and among patients with a BMI ≥18.5kg/m(2) (p<0.001). CONCLUSIONS:TB-infected HIV-positivepatients aged ≥40 years have a slower rate of immune restoration given cART, particularly if BMI is >18.5kg/m(2) or they are female. These patients may benefit from increased monitoring and nutritional support during cART.
Authors: T E Yamashita; J P Phair; A Muñoz; J B Margolick; R Detels; S J O'Brien; J W Mellors; S M Wolinsky; L P Jacobson Journal: AIDS Date: 2001-04-13 Impact factor: 4.177
Authors: Eric Balestre; Serge P Eholié; Amani Lokossue; Papa Salif Sow; Man Charurat; Albert Minga; Joseph Drabo; François Dabis; Didier K Ekouevi; Rodolphe Thiébaut Journal: AIDS Date: 2012-05-15 Impact factor: 4.177
Authors: Ronald J Bosch; Kara Bennett; Ann C Collier; Robert Zackin; Constance A Benson Journal: J Acquir Immune Defic Syndr Date: 2007-03-01 Impact factor: 3.731
Authors: Sophie Grabar; Isabelle Kousignian; Alain Sobel; Philippe Le Bras; Jacques Gasnault; Patricia Enel; Corinne Jung; Aba Mahamat; Jean-Marie Lang; Dominique Costagliola Journal: AIDS Date: 2004-10-21 Impact factor: 4.177
Authors: E A Operskalski; D O Stram; H Lee; Y Zhou; E Donegan; M P Busch; C E Stevens; E R Schiff; S L Dietrich; J W Mosley Journal: J Infect Dis Date: 1995-09 Impact factor: 5.226
Authors: Ezekiel Mupere; Lashaunda Malone; Sarah Zalwango; Allan Chiunda; Alphonse Okwera; Isabel Parraga; Catherine M Stein; Daniel J Tisch; Roy Mugerwa; W Henry Boom; Harriet Mayanja; Christopher C Whalen Journal: Ann Epidemiol Date: 2012-05-09 Impact factor: 3.797
Authors: Hubaida Fuseini; Ben A Gyan; George B Kyei; Douglas C Heimburger; John R Koethe Journal: Curr HIV/AIDS Rep Date: 2021-02-19 Impact factor: 5.071
Authors: Amrei von Braun; Christine Sekaggya-Wiltshire; Alexandra U Scherrer; Brian Magambo; Andrew Kambugu; Jan Fehr; Barbara Castelnuovo Journal: AIDS Res Ther Date: 2017-01-05 Impact factor: 2.250
Authors: Arianna R Means; Kathryn A Risher; Eva L Ujeneza; Innocent Maposa; Joseph Nondi; Steven E Bellan Journal: PLoS One Date: 2016-10-07 Impact factor: 3.240
Authors: Lies Ter Beek; Mathieu S Bolhuis; Harriët Jager-Wittenaar; René X D Brijan; Marieke G G Sturkenboom; Huib A M Kerstjens; Wiel C M de Lange; Simon Tiberi; Tjip S van der Werf; Jan-Willem C Alffenaar; Onno W Akkerman Journal: BMJ Open Date: 2021-12-30 Impact factor: 2.692
Authors: Robert P Igo; Noémi B Hall; LaShaunda L Malone; Jacob B Hall; Barbara Truitt; Feiyou Qiu; Li Tao; Ezekiel Mupere; Audrey Schnell; Thomas R Hawn; William S Bush; Moses Joloba; W Henry Boom; Catherine M Stein Journal: Genes Immun Date: 2018-08-13 Impact factor: 2.676